📋 Tender Overview
Clinical Impact Through Ai-Assisted Ms Care
Precision Medicine For Multiple Sclerosismultiple Sclerosis (Ms) Is A Chronic Inflammatory Disorder Of The Central Nervous System Associated With Myelin Destruction And Neuroaxonal Damage. As Neurons Gradually Lose Their Ability To Transmit Signals, Patients Experience A Variety Of Symptoms And Comorbidities With Debilitating Impact. This Heterogeneous Nature Of Ms Indicates That A One-Size-Fits-All Management And Treatment Approach Is Not Appropriate. Funded By The Horizon Europe Programme, The Claims Project Aims To Make Precision Medicine A Reality For Ms Patients. The Consortium Will Create A Diagnostic Platform That Provides A Comprehensive And Holistic View Of The Patient’S Health Status Through Advanced Diagnostic Technologies. The Goal Is To Predict Disease Progression On An Individual Basis Under Different Treatments And To Improve Patient Outcomes.
Funded Under
Health
Total Cost
€ 9 883 843,75
Eu Contribution
€ 4 783 843,75
Coordinated By
Charite - Universitaetsmedizin Berlin
Germany
